The effect of kefir drink on non-alcoholic fatty liver disease
Phase 3
Recruiting
- Conditions
- non-alcoholic fatty liver disease.non-alcoholic, fatty liver disease
- Registration Number
- IRCT20170916036204N6
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
grade 1,2 & 3 fatty liver, new fatty liver diagnosed patients, and fatty liver confirmed by physician.
Alt>30 in males and ALt>19 in females.
age: 18-65
BMI>25
controlled Diabetes and lipid profile.
Exclusion Criteria
presence of another type of liver disease, cirrhosis, hepatitis B and C, cardiovascular and kidney disease, autoimmune, hypothyroidism, wilson, cystic fibrosis, Deficiency of alpha-1-antitrypsin 1, inflammatory bowel disease and hemochromatosis.
using alcohol
taking nutritional and probiotic supplements within the previous 6 weeks.
having weight loss more than 3 Kg within 3 month ago
participating in other trials in the last 6 month
being pregnant or breast feeding
do not want to participate in this trial.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Alanine aminotransferase. Timepoint: before intervention and 8 weeks after intervention. Method of measurement: ALT kit.;Aspartate transaminase. Timepoint: before intervention and 8 weeks after intervention. Method of measurement: AST kit.;Weight. Timepoint: before intervention and 8 weeks after intervention. Method of measurement: seca scale.
- Secondary Outcome Measures
Name Time Method Blood pressure. Timepoint: before intervention and 8 weeks after intervention. Method of measurement: Mercury barometric device.